NYSE:GMRE

Global Medical REIT (GMRE) Stock Price, News & Analysis

$8.16
-0.03 (-0.37%)
(As of 05:22 PM ET)
Today's Range
$8.05
$8.19
50-Day Range
$7.98
$9.76
52-Week Range
$7.98
$11.59
Volume
507,537 shs
Average Volume
383,430 shs
Market Capitalization
$535.05 million
P/E Ratio
35.48
Dividend Yield
10.29%
Price Target
$11.50

Global Medical REIT MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
40.9% Upside
$11.50 Price Target
Short Interest
Healthy
1.88% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.19
Upright™ Environmental Score
News Sentiment
-0.36mentions of Global Medical REIT in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.56%
From $0.90 to $0.95 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.85 out of 5 stars

Finance Sector

343rd out of 855 stocks

Real Estate Investment Trusts Industry

73rd out of 180 stocks

GMRE stock logo

About Global Medical REIT Stock (NYSE:GMRE)

Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

GMRE Stock Price History

GMRE Stock News Headlines

Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
Global Medical REIT Inc
GMRE Oct 2024 10.000 put
Pentagon contract could send this $2 AI stock soaring
Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...
Q4 2023 Global Medical REIT Inc Earnings Call
City Office REIT (CIO) Q4 FFO Meet Estimates
GMRE Mar 2024 10.000 put
Global Medical REIT Inc's Dividend Analysis
See More Headlines
Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 4/9 Dividend
3/21/2024
Dividend Payable
4/09/2024
Today
4/24/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
N/A
Fax
N/A
Employees
26
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.50
High Stock Price Target
$12.50
Low Stock Price Target
$11.00
Potential Upside/Downside
+40.5%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$20.61 million
Pretax Margin
15.41%

Debt

Sales & Book Value

Annual Sales
$141.05 million
Cash Flow
$1.25 per share
Book Value
$8.10 per share

Miscellaneous

Free Float
60,198,000
Market Cap
$536.69 million
Optionable
Optionable
Beta
1.12
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

GMRE Stock Analysis - Frequently Asked Questions

What is Global Medical REIT's stock price target for 2024?

0 Wall Street research analysts have issued 1-year price targets for Global Medical REIT's shares. Their GMRE share price targets range from $11.00 to $12.50. On average, they expect the company's share price to reach $11.50 in the next year. This suggests a possible upside of 40.9% from the stock's current price.
View analysts price targets for GMRE
or view top-rated stocks among Wall Street analysts.

How have GMRE shares performed in 2024?

Global Medical REIT's stock was trading at $11.10 at the beginning of 2024. Since then, GMRE stock has decreased by 26.5% and is now trading at $8.16.
View the best growth stocks for 2024 here
.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,250,000 shares, an increase of 7.8% from the February 29th total of 1,160,000 shares. Based on an average daily volume of 376,200 shares, the days-to-cover ratio is presently 3.3 days.
View Global Medical REIT's Short Interest
.

When is Global Medical REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our GMRE earnings forecast
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) posted its earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.19. Global Medical REIT had a net margin of 12.55% and a trailing twelve-month return on equity of 3.20%. During the same period in the prior year, the business earned $0.24 earnings per share.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT announced a quarterly dividend on Thursday, March 7th. Stockholders of record on Friday, March 22nd will be paid a dividend of $0.21 per share on Tuesday, April 9th. This represents a $0.84 dividend on an annualized basis and a yield of 10.29%. The ex-dividend date of this dividend is Thursday, March 21st.
Read our dividend analysis for GMRE
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 10.24%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 365.22%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 88.42% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

What ETFs hold Global Medical REIT's stock?
What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

Global Medical REIT (GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different retail and institutional investors. Top institutional shareholders include Sound Income Strategies LLC (1.64%), Allspring Global Investments Holdings LLC (0.35%), Pensionfund DSM Netherlands (0.25%), Royal Fund Management LLC (0.13%), Sumitomo Mitsui Trust Holdings Inc. (0.11%) and Pensionfund Sabic (0.11%). Insiders that own company stock include Henry Cole and Jeffrey Busch.
View institutional ownership trends
.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:GMRE) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners